AGC Biologics is the product of the convergence and integration of Asahi Glass Company (AGC) Bioscience,
CMC Biologics and BIOMEVA GmbH. Our global network spans three continents, with cGMP-compliant facilities in Seattle, WA; Berkeley, CA; Copenhagen, Denmark; Heidelberg, Germany; Yokohama, Japan and Chiba, Japan. Today, our staff of more than 850 dedicated employees is committed to providing solutions for more than 100 customers on five continents.
In keeping with our focus on providing innovative solutions to complex challenges, AGC Biologics is also committed to ecological stewardship and support of the communities in which we operate. We are ISO 14000 certified to ensure that we have processes in place to measure and improve our impact on the environment. We also provide training opportunities for university students and military service members in our local communities who are seeking to develop scientific and technical skills.